Overall, patients with lower expression of the four genes (CCNA2, CCNB1, CCNE1, and CCNF) had worse survival outcomes, which implies that these members of the cyclin family might be ideal prognostic biomarkers for colon cancer. The gene discussed is CCNB1; the disease is colonic neoplasm.